Literature DB >> 19617196

Biomarkers for Alzheimer's disease: ready for the next step.

Paul B Rosenberg1, Argye E Hillis.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617196      PMCID: PMC3491625          DOI: 10.1093/brain/awp184

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


× No keyword cloud information.
  23 in total

1.  Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Abeta42 in humans.

Authors:  Anne M Fagan; Mark A Mintun; Robert H Mach; Sang-Yoon Lee; Carmen S Dence; Aarti R Shah; Gina N LaRossa; Michael L Spinner; William E Klunk; Chester A Mathis; Steven T DeKosky; John C Morris; David M Holtzman
Journal:  Ann Neurol       Date:  2006-03       Impact factor: 10.422

2.  Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo.

Authors:  Randall J Bateman; Ling Y Munsell; John C Morris; Robert Swarm; Kevin E Yarasheski; David M Holtzman
Journal:  Nat Med       Date:  2006-06-25       Impact factor: 53.440

3.  Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults.

Authors:  Anne M Fagan; Catherine M Roe; Chengjie Xiong; Mark A Mintun; John C Morris; David M Holtzman
Journal:  Arch Neurol       Date:  2007-01-08

4.  18F-labeled styrylpyridines as PET agents for amyloid plaque imaging.

Authors:  Wei Zhang; Mei-Ping Kung; Shunichi Oya; Catherine Hou; Hank F Kung
Journal:  Nucl Med Biol       Date:  2006-12-12       Impact factor: 2.408

5.  (18)F-FDG PET database of longitudinally confirmed healthy elderly individuals improves detection of mild cognitive impairment and Alzheimer's disease.

Authors:  Lisa Mosconi; Wai Hon Tsui; Alberto Pupi; Susan De Santi; Alexander Drzezga; Satoshi Minoshima; Mony J de Leon
Journal:  J Nucl Med       Date:  2007-06-15       Impact factor: 10.057

6.  Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.

Authors:  Lisheng Cai; Frederick T Chin; Victor W Pike; Hiroshi Toyama; Jeih-San Liow; Sami S Zoghbi; Kendra Modell; Emmanuelle Briard; H Umesha Shetty; Kathryn Sinclair; Sean Donohue; Dnyanesh Tipre; Mei-Ping Kung; Claudio Dagostin; David A Widdowson; Michael Green; Weiyi Gao; Mary M Herman; Masanori Ichise; Robert B Innis
Journal:  J Med Chem       Date:  2004-04-22       Impact factor: 7.446

7.  Serum sphingomyelins and ceramides are early predictors of memory impairment.

Authors:  Michelle M Mielke; Veera Venkata Ratnam Bandaru; Norman J Haughey; Peter V Rabins; Constantine G Lyketsos; Michelle C Carlson
Journal:  Neurobiol Aging       Date:  2008-05-05       Impact factor: 4.673

8.  Beta-amyloid imaging and memory in non-demented individuals: evidence for preclinical Alzheimer's disease.

Authors:  Kerryn E Pike; Greg Savage; Victor L Villemagne; Steven Ng; Simon A Moss; Paul Maruff; Chester A Mathis; William E Klunk; Colin L Masters; Christopher C Rowe
Journal:  Brain       Date:  2007-10-10       Impact factor: 13.501

9.  Patterns of atrophy differ among specific subtypes of mild cognitive impairment.

Authors:  Jennifer L Whitwell; Ronald C Petersen; Selamawit Negash; Stephen D Weigand; Kejal Kantarci; Robert J Ivnik; David S Knopman; Bradley F Boeve; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2007-08

10.  11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment.

Authors:  Clifford R Jack; Val J Lowe; Matthew L Senjem; Stephen D Weigand; Bradley J Kemp; Maria M Shiung; David S Knopman; Bradley F Boeve; William E Klunk; Chester A Mathis; Ronald C Petersen
Journal:  Brain       Date:  2008-02-07       Impact factor: 13.501

View more
  4 in total

1.  Widespread white matter degeneration preceding the onset of dementia.

Authors:  Klaus H Maier-Hein; Carl-Fredrik Westin; Martha E Shenton; Michael W Weiner; Ashish Raj; Philipp Thomann; Ron Kikinis; Bram Stieltjes; Ofer Pasternak
Journal:  Alzheimers Dement       Date:  2014-07-14       Impact factor: 21.566

Review 2.  Cerebrospinal fluid and blood biomarkers in Alzheimer's disease.

Authors:  Christian Humpel; Tanja Hochstrasser
Journal:  World J Psychiatry       Date:  2011-12-31

3.  Harnessing neuroplasticity for clinical applications.

Authors:  Steven C Cramer; Mriganka Sur; Bruce H Dobkin; Charles O'Brien; Terence D Sanger; John Q Trojanowski; Judith M Rumsey; Ramona Hicks; Judy Cameron; Daofen Chen; Wen G Chen; Leonardo G Cohen; Christopher deCharms; Charles J Duffy; Guinevere F Eden; Eberhard E Fetz; Rosemarie Filart; Michelle Freund; Steven J Grant; Suzanne Haber; Peter W Kalivas; Bryan Kolb; Arthur F Kramer; Minda Lynch; Helen S Mayberg; Patrick S McQuillen; Ralph Nitkin; Alvaro Pascual-Leone; Patricia Reuter-Lorenz; Nicholas Schiff; Anu Sharma; Lana Shekim; Michael Stryker; Edith V Sullivan; Sophia Vinogradov
Journal:  Brain       Date:  2011-04-10       Impact factor: 13.501

4.  Regions of interest computed by SVM wrapped method for Alzheimer's disease examination from segmented MRI.

Authors:  Antonio R Hidalgo-Muñoz; Javier Ramírez; Juan M Górriz; Pablo Padilla
Journal:  Front Aging Neurosci       Date:  2014-02-20       Impact factor: 5.750

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.